Cannabis Bioscience International Holdings, Inc.
cbih.comAI Executive Summary
AI-powered analysis of 10-Q filing content
Cannabis Bioscience International Holdings is in severe financial distress with only $132 in cash versus $1.4M in total liabilities, creating a $1.36M stockholder deficiency. Revenue declined 69% year-over-year to $77K while the company burned through nearly all its cash reserves and continues posting significant operating losses.
Red Flags Detected (7)
Critical liquidity crisis with only $132 in cash on hand
$1.36M stockholder deficiency indicating technical insolvency
Revenue collapsed 69% from $253K to $77K year-over-year
4 more red flags detected
Key Takeaways
Company is essentially out of cash with massive liabilities
Revenue performance deteriorated significantly year-over-year
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.